Consensus Omnicell, Inc.

Stocks

OMCL

US68213N1090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-18 EDT			5-day change	1st Jan Change
39.05 ^USD	+1.43%		+3.22%	-13.80%

06-09	Omnicell, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03:20 PM
06-08	Omnicell, Inc. Announces Appointment of Dan Mandoli to Senior Vice President and General Manager, Specialty Pharmacy Services	CI

Evolution of the Average Target: Omnicell, Inc.

Evolution of the Target Price: Omnicell, Inc.

Changes in Analyst Recommendations: Omnicell, Inc.

a9dd58bf571c2234dbc8.s1qH9yJ5LhCOvPYlnMSScAp1nJZ9rUoo6bwSjo8ce5Q.9W3tzkkJeHn387lH9_2hCHowr6Er6TNQvetmt9xpNNvnYv-CfSpUR-_fow~5dacb87c2ff522bacf53b72281694468

Analysts' recommendations: Omnicell, Inc.

02-04	BofA Upgrades Omnicell to Buy From Neutral	MT
01-08	Omnicell Shares Rise After KeyBanc Upgrade	MT
01-08	KeyBanc Upgrades Omnicell to Overweight From Sector Weight, $60 Price Target	MT
25-05-23	Piper Sandler Adjusts Omnicell Price Target to $57 From $46, Maintains Overweight Rating	MT
25-05-14	Wells Fargo Upgrades Omnicell to Overweight From Equal Weight, Adjusts Price Target to $35 From $31	MT
25-01-06	BofA Securities Adjusts Price Target on Omnicell to $46 From $54	MT
24-10-31	BofA Securities Downgrades Omnicell to Neutral From Buy, Adjusts Price Target to $57 From $44	MT
24-08-02	Barclays Upgrades Omnicell to Equalweight From Underweight, Adjusts Price Target to $39 From $26	MT
24-02-09	Wells Fargo Adjusts Price Target on Omnicell to $26 From $28, Maintains Equal-Weight Rating	MT
23-11-03	Piper Sandler Upgrades Omnicell to Overweight From Neutral, Cuts Price Target to $39 From $70	MT
23-11-03	BTIG Downgrades Omnicell to Neutral From Buy	MT
23-11-03	Wells Fargo Upgrades Omnicell to Equal-Weight From Underweight, Adjusts Price Target to $28 From $39	MT
23-10-11	KeyBanc Downgrades Omnicell to Sector Weight From Overweight, Cites 'More Muted' Outlook for Top, Bottom Lines	MT
23-10-03	Benchmark Cuts Price Target on Omnicell to $70 From $88, Maintains Buy Rating	MT
23-09-26	Wells Fargo Adjusts Omnicell Price Target to $39 From $56, Maintains Underweight Rating	MT
23-08-04	KeyBanc Adjusts Price Target on Omnicell to $75 From $80, Maintains Overweight Rating	MT
23-08-02	Piper Sandler Downgrades Omnicell to Neutral From Overweight, Adjusts Price Target to $70 From $66	MT
23-07-20	Wells Fargo Downgrades Omnicell to Underweight From Overweight, Cuts Price Target to $56 From $65	MT
23-07-13	KeyBanc Adjusts Price Target on Omnicell to $80 From $70, Maintains Overweight Rating	MT
23-06-15	Benchmark Capital Adjusts Omnicell Price Target to $88 From $68, Maintains Buy Rating	MT
23-05-03	KeyBanc Adjusts Price Target on OOmnicell MCL to $70 From $65, Maintains Overweight Rating	MT
23-03-02	KeyBanc Adjusts Price Target on Omnicell to $65 From $70, Keeps Overweight Rating	MT
23-02-27	Benchmark Upgrades Omnicell to Buy From Hold, Price Target is $68	MT
23-02-02	KeyBanc Adjusts Price Target on Omnicell to $70 From $75, Maintains Overweight Rating	MT
23-01-27	Piper Sandler Adjusts Omnicell's Price Target to $66 From $55, Keeps Overweight Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Objective/dr gap
OMNICELL, INC.		+56.94%
VEEVA SYSTEMS INC.		+60.13%
PRO MEDICUS LIMITED		+4.42%
SECTRA AB		+21.63%
HEARTFLOW, INC.		+9.99%
GENERATE BIOMEDICINES, INC.		+75.29%
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-	+21.58%
B-SOFT CO.,LTD.		+74.13%
RAYSEARCH LABORATORIES AB	-	+58.65%
YIDU TECH INC.	-	+75.05%
Average		+45.78%
Weighted average by Cap.		+39.96%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

39.05USD

Average target price

61.29USD

Spread / Average Target

+56.94%

High Price Target

70.00USD

Spread / Highest target

+79.26%

Low Price Target

55.00USD

Spread / Lowest Target

+40.85%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BofA Securities
KeyBanc Capital Markets
Piper Sandler
Wells Fargo Securities
BTIG
Benchmark Company
Berenberg Bank
JPMorgan Chase
SVB Securities LLC
Craig-Hallum
Benchmark Capital